Shape and size engineered cellulosic nanomaterials as broad spectrum anti-microbial compounds.

Int J Biol Macromol

CSIR-National Chemical Laboratory, Polymer Science & Engineering Division, Dr. Homi Bhabha Road, Pune 411008, India. Electronic address:

Published: June 2016

AI Article Synopsis

  • Oxidized celluloses have a long history as antimicrobial materials, and this study reports the creation of new spherical nanoparticles made from 2,3,6-tricarboxycellulose.
  • The nanoparticles, sized between 25-35nm, demonstrated effectiveness against a variety of bacteria, including both non-pathogenic and pathogenic strains in lab tests.
  • The findings suggest these nanoparticles could serve as both a drug delivery system and an antimicrobial treatment, especially for diseases like tuberculosis, despite requiring higher concentrations compared to traditional drugs like Isoniazid.

Article Abstract

Oxidized celluloses have been used for decades as antimicrobial wound gauzes and surgical cotton. We now report the successful synthesis of a next generation narrow size range (25-35nm) spherical shaped nanoparticles of 2,3,6-tricarboxycellulose based on cellulose I structural features, for applications as new antimicrobial materials. This study adds to our previous study of 6-carboxycellulose. A wide range of bacteria such as Escherichia coli, Staphloccocus aureus, Bacillus subtilis and Mycobacterium tuberculosis (non-pathogenic as well as pathogenic strains) were affected by these polymers in in vitro studies. Activity against Mycobacteria were noted at high concentrations (MIC99 values 250-1000μg/ml, as compared to anti-TB drug Isoniazid 0.3μg/ml). However, the broad spectrum activity of oxidized celluloses and their nanoparticles against a wide range of bacteria, including Mycobacteria, show that these materials are promising new biocompatible and biodegradable drug delivery vehicles wherein they can play the dual role of being a drug encapsulant as well as a broad spectrum anti-microbial and anti-TB drug.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijbiomac.2016.02.024DOI Listing

Publication Analysis

Top Keywords

broad spectrum
12
spectrum anti-microbial
8
oxidized celluloses
8
wide range
8
range bacteria
8
anti-tb drug
8
shape size
4
size engineered
4
engineered cellulosic
4
cellulosic nanomaterials
4

Similar Publications

Discovery of Metabolic Reprogramming 2-Quinolones as Effective Antimicrobials for MRSA-Infected Wound Therapy.

J Med Chem

January 2025

State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun 130062, China.

To date, the abuse of antibiotics and a gradual decline in novel antibiotic discovery enlarge the threat of drug-resistant bacterial infections, especially methicillin-resistant (MRSA). Herein, inspired by the unique structures and antibacterial activities of 2-quinolones, a class of novel 2-quinolones with substituted pyridines was synthesized. Notably, compound , the derivative with a methylpyridine fragment, showed potent antibacterial and antibiofilm activities, especially for MRSA strains (MIC = 0.

View Article and Find Full Text PDF

Efflux pumps that transport antibacterial drugs out of bacterial cells have broad specificity, commonly leading to broad spectrum resistance and limiting treatment strategies for infections. It remains unclear how efflux pumps can maintain this broad spectrum specificity to diverse drug molecules while limiting the efflux of other cytoplasmic content. We have investigated the origins of this broad specificity using theoretical models informed by the experimentally determined structural and kinetic properties of efflux pumps.

View Article and Find Full Text PDF

Lipopolysaccharides (LPS) are major components of Gram-negative bacteria. LPS not only induce endotoxemia and inflammation, but also contribute to various diseases. In experimental settings, LPS administration serves as a model for acute inflammatory responses.

View Article and Find Full Text PDF

Nonantibiotic strategies are urgently needed to treat acute drug-resistant bacterial pneumonia. Recently, nanomaterial-mediated bacterial cuproptosis has arisen widespread interest due to its superiority against antibiotic resistance. However, it may also cause indiscriminate and irreversible damage to healthy cells.

View Article and Find Full Text PDF

Immuno-oncology in the daily practice.

Curr Opin Oncol

January 2025

Gustave Roussy Departement Interdisciplinaire de Soins de Support aux Patients en Onco-hematologie, Villejuif, France.

Purpose Of Review: Immune checkpoint inhibitors (ICI) have become an integral part of oncology treatment. ICI currently has approval for more than thirty tumor types with proven efficacy. However, ICI can expose patients to inflammatory side effects, such as immuno-related adverse events (irAE).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!